| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |